Johnson & Johnson (JNJ)
268.73
+2.43
(+0.91%)
USD |
NYSE |
Oct 27, 16:00
265.65
-3.08
(-1.15%)
Pre-Market: 09:20
Johnson & Johnson Market Cap : 646.86B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 646.86B |
| October 26, 2026 | 641.02B |
| October 23, 2026 | 635.02B |
| October 22, 2026 | 644.17B |
| October 21, 2026 | 620.51B |
| October 20, 2026 | 624.31B |
| October 19, 2026 | 610.90B |
| October 16, 2026 | 615.16B |
| October 15, 2026 | 609.96B |
| October 14, 2026 | 611.47B |
| October 13, 2026 | 598.71B |
| October 12, 2026 | 635.12B |
| October 09, 2026 | 629.61B |
| October 08, 2026 | 617.66B |
| October 07, 2026 | 622.41B |
| October 06, 2026 | 613.57B |
| October 05, 2026 | 609.11B |
| October 02, 2026 | 616.58B |
| October 01, 2026 | 622.91B |
| September 30, 2026 | 637.55B |
| September 29, 2026 | 644.37B |
| September 28, 2026 | 654.92B |
| September 25, 2026 | 653.16B |
| September 24, 2026 | 651.86B |
| September 23, 2026 | 648.22B |
| Date | Value |
|---|---|
| September 22, 2026 | 648.27B |
| September 21, 2026 | 648.95B |
| September 18, 2026 | 650.20B |
| September 17, 2026 | 650.75B |
| September 16, 2026 | 643.67B |
| September 15, 2026 | 643.48B |
| September 14, 2026 | 641.36B |
| September 11, 2026 | 639.58B |
| September 10, 2026 | 641.43B |
| September 09, 2026 | 643.19B |
| September 08, 2026 | 648.10B |
| September 04, 2026 | 662.82B |
| September 03, 2026 | 670.52B |
| September 02, 2026 | 662.77B |
| September 01, 2026 | 653.09B |
| August 31, 2026 | 640.23B |
| August 28, 2026 | 645.50B |
| August 27, 2026 | 640.03B |
| August 26, 2026 | 650.22B |
| August 25, 2026 | 657.78B |
| August 24, 2026 | 657.54B |
| August 21, 2026 | 650.80B |
| August 20, 2026 | 643.89B |
| August 19, 2026 | 658.43B |
| August 18, 2026 | 652.89B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.207T |
| Merck & Co., Inc. | 350.10B |
| Pfizer Inc. | 169.83B |
| Bristol Myers Squibb Co. | 125.75B |
| Abbott Laboratories | 178.40B |
Market Cap Related Metrics
| PE Ratio | 40.76 |
| PS Ratio | 6.609 |
| Price to Book Value | 7.934 |
| Price to Free Cash Flow | 32.86 |
| Price | 268.73 |
| Earnings Yield | 2.45% |
| Operating PE Ratio | 25.57 |
| Normalized PE Ratio | 28.98 |